JoshuaMHareMD

Cardiology • Miami, FL

Adult Congenital Heart Disease, Heart Failure & Transplantation

Professor, Medicine, University of Miami Leonard M. Miller School of Medicine

Join to view full profile

Dr. Hare is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hare's full profile

Already have an account?

Office
1400 Nw 12th Avenue
Suite A
Miami, FL 33136
Phone+1 305-243-1900
Is this information wrong?

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1991 - 1994
Johns Hopkins UniversityResidency, Internal Medicine, 1988 - 1991
Johns Hopkins University School of MedicineClass of 1988

Certifications & Licensure

MA State Medical License 1991 - 2026
FL State Medical License 2007 - 2025
MD State Medical License 1995 - 2022
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2008-2014
Top Doctors:South Florida Castle Connolly, 2012
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Elected Member The American Society for Clinical Investigation, 2003
Fellow (FACC) American College of Cardiology
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure Start of enrollment: 2003 Mar 01
Completed
Phase 2, Phase 3
Safety Study of Adult Mesenchymal Stem Cells (MSC) to Treat Acute Myocardial Infarction Start of enrollment: 2005 Mar 22
Completed
Phase 1
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) Start of enrollment: 2007 Nov 01
Terminated
Phase 1, Phase 2
The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT) Start of enrollment: 2008 Aug 01
Completed
Phase 1, Phase 2
PercutaneOus StEm Cell Injection Delivery Effects On Neomyogenesis in Dilated CardioMyopathy (The POSEIDON-DCM Study) Start of enrollment: 2011 May 19
Completed
Phase 1, Phase 2
An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) Start of enrollment: 2013 Feb 20
Completed
Phase 2
Patients With Intermittent Claudication Injected With ALDH Bright Cells Start of enrollment: 2013 Jun 01
Completed
Phase 2
The TRansendocardial Stem Cell Injection Delivery Effects on Neomyogenesis STudy (The TRIDENT Study) Start of enrollment: 2014 Feb 13
Completed
Phase 2
Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) Start of enrollment: 2013 Nov 13
Terminated
Phase 1
AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery Start of enrollment: 2014 Mar 03
Completed
Phase 1, Phase 2
The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial. Start of enrollment: 2025 Mar 01
Withdrawn
Phase 1, Phase 2
Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression Start of enrollment: 2017 Oct 31
Terminated
Phase 1
Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis Start of enrollment: 2020 Dec 01
Withdrawn
Phase 1
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression. Start of enrollment: 2018 Apr 12
Terminated
Phase 1, Phase 2
A Comparative Study of Subjects Past Their Final Follow-ON Visit Start of enrollment: 2016 Jun 23
Completed
Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. Start of enrollment: 2018 Mar 18
Recruiting
Phase 1, Phase 2
The CHILD Trial: Hypoplastic Left Heart Syndrome Study. Start of enrollment: 2019 Oct 16
Recruiting
Phase 1
Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain Start of enrollment: 2020 Dec 01
Withdrawn
Phase 1, Phase 2
Lomecel-B Delivered During Stage II Surgery for Hypoplastic Left Heart Syndrome (ELPIS) Start of enrollment: 2018 Feb 21
Active, not recruiting
Phase 1, Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy Start of enrollment: 2021 May 07
Recruiting
Phase 2
Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19 Start of enrollment: 2022 Oct 01
Withdrawn
Phase 1
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD) Start of enrollment: 2021 Aug 16
Recruiting
Phase 1, Phase 2
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy Start of enrollment: 2024 Mar 04
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Rises in Hematocrit Are Associated With an Increased Risk of Major Adverse Cardiovascular Events in Men Starting Testosterone Therapy: A Retrospective Cohort Claims Da...
Taylor P Kohn, Pranjal Agrawal, Jesse Ory, Ranjith Ramasamy, Hare, J.> ;The Journal of Urology. 2024 Feb 1
Mesenchymal STRO-1/STRO-3precursor cells for the treatment of chronic heart failure with reduced ejection fraction.
Andrew Sundin, Simona I Ionescu, Wayne Balkan, Joshua M Hare> ;Future Cardiology. 2023 Sep 1
Cell-based therapy to boost right ventricular function and cardiovascular performance in hypoplastic left heart syndrome: Current approaches and future directions.
Kevin Williams, Aisha Khan, Yee-Shuan Lee, Joshua M Hare> ;Seminars in Perinatology. 2023 Apr 1
4 citations
Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
Sunjay Kaushal, Joshua M Hare, Jessica R Hoffman, Riley M Boyd, Kevin N Ramdas, Nicholas Pietris, Shelby Kutty, James S Tweddell, S Adil Husain, Shaji C Menon, Linda M...> ;European Heart Journal Open. 2023 Mar 1
3 citations
Neonatal intermittent hypoxia persistently impairs lung vascular development and induces long-term lung mitochondrial DNA damage.
Andreas Damianos, Shathiyah Kulandavelu, Pingping Chen, Patrick Nwajei, Sunil Batlahally, Mayank Sharma, Silvia Alvarez-Cubela, Juan Dominguez-Bendala, Ronald Zambrano...> ;Journal of Applied Physiology. 2022 Nov 1
2 citations
S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer.
Fakiha Firdaus, Manish Kuchakulla, Rehana Qureshi, Raul Ariel Dulce, Yash Soni, Derek J Van Booven, Khushi Shah, Thomas Masterson, Omar Joel Rosete, Sanoj Punnen, Josh...> ;Cell Death & Disease. 2022 Oct 8
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document ...
Bettina Heidecker, Noa Dagan, Ran Balicer, Urs Eriksson, Giuseppe Rosano, Andrew Coats, Carsten Tschöpe, Sebastian Kelle, Gregory A Poland, Andrea Frustaci, Karin Klin...> ;European Journal of Heart Failure. 2022 Nov 1
3 citations
Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression.
Monique Williams, Jose Manuel Condor Capcha, Camila Iansen Irion, Grace Seo, Guerline Lambert, Ali Kamiar, Keyan Yousefi, Rosemeire Kanashiro-Takeuchi, Lauro Takeuchi,...> ;Journal of the American Heart Association. 2022 Sep 6
12 citations
Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
Mayank Sharma, Michael A Bellio, Merline Benny, Shathiyah Kulandavelu, Pingping Chen, Chawisa Janjindamai, Chenxu Han, Liming Chang, Shanique Sterling, Kevin Williams,...> ;Stem Cells Translational Medicine. 2022 Aug 23
3 citations
Comparative efficacy and mechanism of action of cardiac progenitor cells after cardiac injury.
Muthukumar Gunasekaran, Rachana Mishra, Progyaparamita Saha, David Morales, Wen-Chih Cheng, Arun R Jayaraman, Jessica R Hoffman, Lauran Davidson, Ling Chen, Aakash M S...> ;Iscience. 2022 Aug 19
Potential of Stem Cell-Based Therapy to Restore Function in Aging Systems: Are We There Yet?
Joshua M Hare, Isabel Beerman> ;The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2022 Jul 5
Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study.
Laarni Ibenana, Robert Anderson, Adrian Gee, Margaret Gilbert, Cheryl Cox, Joshua M Hare, Adriana Brooks, Linda Kelley, Aisha Khan, Natalia Lapteva, Aaron Orozco, Davi...> ;Cytotherapy. 2022 Jul 1
4 citations
Long-term cardiac surveillance and outcomes of COVID-19 patients.
Raul D Mitrani, Nitika Dabas, Jarrah Alfadhli, Maureen H Lowery, Thomas M Best, Joshua M Hare, Robert J Myerburg, Jeffrey J Goldberger> ;Trends in Cardiovascular Medicine. 2022 Nov 1
6 citations
Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of heart failure with preserved ejection fraction.
Raul A Dulce, Rosemeire M Kanashiro-Takeuchi, Lauro M Takeuchi, Alessandro G Salerno, Amarylis C B A Wanschel, Shathiyah Kulandavelu, Wayne Balkan, Marilia S S R Zutti...> ;Cardiovascular Research. 2023 Feb 3
4 citations
Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds.
Camila I Irion, Monique Williams, Jose Condor Capcha, Trevor Eisenberg, Guerline Lambert, Lauro M Takeuchi, Grace Seo, Keyvan Yousefi, Rosemeire Kanashiro-Takeuchi, Ke...> ;International Journal of Molecular Sciences. 2022 Jun 15
4 citations
Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publica...
Mariann Gyöngyösi, Evgeny Pokushalov, Aleksander Romanov, Emerson Perin, Joshua M Hare, Jens Kastrup, Francisco Fernández-Avilés, Ricardo Sanz-Ruiz, Anthony Mathur, Wo...> ;Journal of Clinical Medicine. 2022 Jun 4
17 citations
Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Ther...
Jesse Ory, Sirpi Nackeeran, Navin C Balaji, Joshua M Hare, And Ranjith Ramasamy> ;The Journal of Urology. 2022 Jun 1
1 citations
Bilateral pneumonectomy and lung transplant for COVID-19-induced respiratory failure.
Ali Ghodsizad, April A Grant, Asif N Mohammed, Jose Navas-Blanco, Arjang Ruhparwar, Mehdi Mirsaeidi, Joshua M Hare, Eduardo DeMarchena, Matthias Loebe> ;JTCVS Techniques. 2022 Jun 1
Regenerating Endothelium and Restoring Microvascular Endothelial Function.
Joshua M Hare, Phillip Yang> ;JACC. Cardiovascular Imaging. 2022 May 1
5 citations
Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
Sunjay Kaushal, Joshua M Hare, Aakash M Shah, Nicholas P Pietris, Judith L Bettencourt, Linda B Piller, Aisha Khan, Abigail Snyder, Riley M Boyd, Mohamed Abdullah, Rac...> ;Pediatric Cardiology. 2022 Oct 1
8 citations
Mechanism of Action of Mesenchymal Stem Cells (MSCs): impact of delivery method.
Luiza L Bagno, Alessandro G Salerno, Wayne Balkan, Joshua M Hare> ;Expert Opinion on Biological Therapy. 2022 Apr 1
18 citations
Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease.
Mark Brody, Marc Agronin, Brad J Herskowitz, Susan Y Bookheimer, Gary W Small, Benjamin Hitchinson, Kevin Ramdas, Tyler Wishard, Katalina Fernández McInerney, Bruno Ve...> ;Alzheimer's & Dementia. 2023 Jan 1
2 citations
Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
Merline Benny, Benjamin Courchia, Sebastian Shrager, Mayank Sharma, Pingping Chen, Joanne Duara, Krystalenia Valasaki, Michael A Bellio, Andreas Damianos, Jian Huang, ...> ;Stem Cells Translational Medicine. 2022 Mar 17
1 citations
Free-breathing gradient recalled echo-based CMR in a swine heart failure model.
Craig C Morris, Jacob Ref, Satya Acharya, Kevin J Johnson, Scott Squire, Tuschar Acharya, Tyler Dennis, Sherry Daugherty, Alice McArthur, Ikeotunye Royal Chinyere, Jen...> ;Scientific Reports. 2022 Mar 8
5 citations
Leptin secreted from testicular microenvironment modulates hedgehog signaling to augment the endogenous function of Leydig cells.
Himanshu Arora, Rehana Qureshi, Kajal Khodamoradi, Deepa Seetharam, Madhumita Parmar, Derek J Van Booven, Isabelle Catherine Issa, Robert Sackstein, Dolores Lamb, Josh...> ;Cell Death & Disease. 2022 Mar 4
Join now to see all

Journal Articles

Alterations of Tumor Microenvironment by Nitric Oxide Impedes Castration-Resistant Prostate Cancer Growth
Ranjith Ramasamy, Kush Panara, Himanshu Arora, Joshua M Hare, Proceedings of the National Academy of Sciences
Growth Hormone-Releasing Hormone Attenuates Cardiac Hypertrophy and Improves Heart Function in Pressure Overload-Induced Heart Failure
Joshua Hare, MD, Proceedings of the National Academy of Sciences

Press Mentions

‘Miami Valves’ International Conference Showcases Advances in Treating Cardiovascular DiseaseMarch 3rd, 2023
Heart Disease Study Shows Hope for Stem Cell TreatmentFebruary 27th, 2023
Mesenchymal Stem Cells as Living Anti-Inflammatory Therapy for COVID-19 Related Acute Respiratory Distress SyndromeOctober 26th, 2020
Join now to see all

Grant Support

Cell Based Therapy For Non-Ischemic Dilated CardiomyopathyNational Heart, Lung, And Blood Institute2012
Cardioprotective Effect Of Growth Hormone Releasing HormoneNational Heart, Lung, And Blood Institute2011–2012
Nitroso/Redox Balance In Myocardial InfarctionNational Heart, Lung, And Blood Institute2009–2012
Stem Cells For Dilated CardiomyopathyNational Heart, Lung, And Blood Institute2011
Autologous Adult Myocardial Cardioblasts To Treat Ischemic Heart FailureNational Heart, Lung, And Blood Institute2010–2011
Cellular Cardiomyoplasty For Chronic Heart FailureNational Heart, Lung, And Blood Institute2007–2011
Mesenchymal Stem Cell CardiomyoplastyNational Heart, Lung, And Blood Institute2007–2009
Oxidative Stress In Heart FAILURE: MechanismsNational Heart, Lung, And Blood Institute2007–2008
Aging Impairs Stem-Cell Mediated Myocardial RepairNational Institute On Aging2006–2008
Safety Of Mesenchymal Stem CellsNational Center For Research Resources2006–2007
Mesenchymal Stem Cell CardiomyoplastyNational Heart, Lung, And Blood Institute2005–2006
Aging Impairs Stem-Cell Mediated Myocardial RepairNational Institute On Aging2004–2006
Oxidative Stress In Heart FAILURE: MechanismsNational Heart, Lung, And Blood Institute2000–2006
Core A- Administrative CoreNational Heart, Lung, And Blood Institute2005
Cellular Cardiomyoplasty For Acute And Chronic IschemicNational Heart, Lung, And Blood Institute2005
Mesenchymal Stem Cells And Ventricular RemodelingNational Heart, Lung, And Blood Institute2002–2004
Nitric Oxide, Cardiac Contractility, And Heart FailureNational Heart, Lung, And Blood Institute1995–1999
Nitric Oxide, Cardiac Contractility, And Heart FailureNational Heart, Lung, And Blood Institute1995